101 related articles for article (PubMed ID: 11323016)
1. Matrix metalloproteinase deficiencies do not impair cell-associated fibrinolytic activity.
Ugwu F; Lemmens G; Collen D; Lijnen HR
Thromb Res; 2001 Apr; 102(1):61-9. PubMed ID: 11323016
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and cellular fibrinolytic activity.
Lijnen HR
Biochemistry (Mosc); 2002 Jan; 67(1):92-8. PubMed ID: 11841344
[TBL] [Abstract][Full Text] [Related]
3. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
4. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
[TBL] [Abstract][Full Text] [Related]
5. Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury.
Lijnen HR
Verh K Acad Geneeskd Belg; 2001; 63(6):605-22. PubMed ID: 11813512
[TBL] [Abstract][Full Text] [Related]
6. Elements of the fibrinolytic system.
Lijnen HR
Ann N Y Acad Sci; 2001; 936():226-36. PubMed ID: 11460480
[TBL] [Abstract][Full Text] [Related]
7. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).
Ugwu F; Lemmens G; Collen D; Lijnen HR
Thromb Haemost; 1999 Sep; 82(3):1127-31. PubMed ID: 10494776
[TBL] [Abstract][Full Text] [Related]
8. Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activator.
Lijnen HR; Dewerchin M; De Cock F; Collen D
Thromb Res; 1990 Feb; 57(3):333-42. PubMed ID: 2107593
[TBL] [Abstract][Full Text] [Related]
9. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
Carmeliet P; Moons L; Dewerchin M; Rosenberg S; Herbert JM; Lupu F; Collen D
J Cell Biol; 1998 Jan; 140(1):233-45. PubMed ID: 9425170
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of plasmin-mediated prostromelysin-1 activation by interaction of long chain unsaturated fatty acids with kringle 5.
Huet E; Cauchard JH; Berton A; Robinet A; Decarme M; Hornebeck W; Bellon G
Biochem Pharmacol; 2004 Feb; 67(4):643-54. PubMed ID: 14757164
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
Orbe J; Barrenetxe J; Rodriguez JA; Vivien D; Orset C; Parks WC; Birkland TP; Serrano R; Purroy A; Martinez de Lizarrondo S; Angles-Cano E; Páramo JA
Circulation; 2011 Dec; 124(25):2909-19. PubMed ID: 22104553
[TBL] [Abstract][Full Text] [Related]
12. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
Ries M; Zenker M; Gaffney PJ
Thromb Res; 2000 Nov; 100(4):341-51. PubMed ID: 11113278
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration.
Cullen JP; Nicholl SM; Sayeed S; Sitzmann JV; Okada SS; Cahill PA; Redmond EM
Thromb Res; 2004; 114(1):57-65. PubMed ID: 15262486
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes.
Hotary KB; Yana I; Sabeh F; Li XY; Holmbeck K; Birkedal-Hansen H; Allen ED; Hiraoka N; Weiss SJ
J Exp Med; 2002 Feb; 195(3):295-308. PubMed ID: 11828004
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
Lijnen HR; Wagner EF; Collen D
Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins.
Hiraoka N; Allen E; Apel IJ; Gyetko MR; Weiss SJ
Cell; 1998 Oct; 95(3):365-77. PubMed ID: 9814707
[TBL] [Abstract][Full Text] [Related]
17. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
[TBL] [Abstract][Full Text] [Related]
18. Effect of pulse pressure on vascular smooth muscle cell migration: the role of urokinase and matrix metalloproteinase.
Redmond EM; Cahill PA; Hirsch M; Wang YN; Sitzmann JV; Okada SS
Thromb Haemost; 1999 Feb; 81(2):293-300. PubMed ID: 10064009
[TBL] [Abstract][Full Text] [Related]
19. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
